The federal court has overturned the conviction of a former regional vice president of assisted suicide group Exit for having helped a healthy 86-year-old woman to die. The case has been sent back to the cantonal court in Geneva.
This content was published on
2 minutes
Keystone-SDA/RTS/dos
Español
es
El Tribunal Federal anula condena por asistencia al suicidio
In 2019, retired doctor Pierre Beck was found guilty of breaking the federal law on medicinal products and given a suspended 120-day jail sentence, after he helped a healthy 86-year-old woman who wanted to die with her ill husband. Beck provided the woman with a lethal dose of the sedative and preanesthetic pentobarbital.
On Thursday, the Federal Court in Lausanne overturned this decision. Although judges were divided about the legality and nuances of the case, a majority of three against two concluded that Beck could not be found guilty under the Federal Act on Medicinal Products, but that the case should go back to the cantonal court in Geneva and be examined under the Federal Act on Narcotics and Psychotropic Substances, which includes pentobarbital.
Motives
Swiss law (article 115External link of the Criminal Code) criminalises cases of assisted suicide when the help is driven by “selfish motives”. However, as the RTS public broadcaster reported on Thursday, the article offers much room for interpretation.
In the initial verdict in 2019, Beck was deemed to have agreed to the woman’s request through altruism, but also a certain amount of personal conviction. It was also deemed that he should have sought the advice of other doctors before going ahead. Beck himself said he was faced with a choice between offering the woman a peaceful death alongside her husband, or running the risk of her opting for a “violent suicide”.
On Thursday, Beck repeated to RTS public television that he “carried out the act with full medical conscientiousness”.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Why these Japanese patients wanted to die in Switzerland
This content was published on
In our podcast series on assisted suicide, we hear what it was like to accompany two people who came to Switzerland to die.
This content was published on
A Japanese man came all the way to Switzerland to die. SWI swissinfo.ch accompanied him on the final part of his journey. This is his story.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.